Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

CADILA SET TO LAUNCH DESI VIAGRA BY '99

Article Abstract:

Cadila Healthcare Ltd plans to launch the Indian version of Viagra by mid-1999. It has synthesised sildenafil citrate, the chemical compound used in Viagra. It has sought permission from the Drug Controller of India for clinical trials of the drug, named Penigra. A single capsule of Penigra is likely to cost Rs85. As the patents for pharmaceutical products comes into effect in 2005 AD, the compound can be manufactured and marketed in India. The compound is manufactured by 3 other pharmaceutical companies in India. (rk)

Comment:

Plans to launch Indian version of Viagra by mid-1999 & has sought permission from DCI for clinical trials of drug, named Penigra

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1998
Product information, Prostate Disorder Preparations, Prostate agents, Cadila Healthcare Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


CADILA PROMOTERS MAKE OPEN OFFER FOR 47% OF CASIL HEALTH

Article Abstract:

Cadila Pharmaceuticals (CP) has made an open offer for buying out 47.48 percent stake in Casil Health Products Ltd (CHPL). The fully paid-up shares will be purchased at a price of Rs5.75 per share and partly paid-up shares at Rs0.75 per share. The shares were quoted at Rs5.40 on the Bombay Stock Exchange on May 27, 1998. CHPL makes disposable syringes, needles, gloves and sulfolane. The equity share capital of the company is Rs3.49 crore. CHPL had accumulated losses of Rs5.56 crore as on December 31, 1997. (gs)

Comment:

Makes open offer for buying out 47.48% stake in Casil Health Products, w/ fully paid-up shares being purchased at Rs5.75/share

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1998
Asset sales & divestitures, Acquisitions & mergers, Pharmaceutical Preparations, Surgical and Medical Instrument Manufacturing, Hypodermic Syringes & Related Eqp, Drugs, Casil Health Products Ltd., Cadila Pharmaceuticals Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


ZYDUS CADILA RELEASES NEW DRUG

Article Abstract:

Zydus Cadila has launched Meloxicam for the first time in the country under the brand name of Mel-OD. The drug is used to treat degenerative diseases like osteoarthritis and rheumatoid arthritis. Meloxicam is the first of the COX-2 inhibitors to be introduced the world over. (khr)

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1999
Product introduction, Pharmaceutical preparations, Osteoporosis Therapeutic Preps, Bone disorder agents, Zydus Cadila

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: India, Article
Similar abstracts:
  • Abstracts: STANCHART POSTS Rs66.7-CR NET STANCHART LAUNCHES INSTABUYS CREDIT CARD INSTALLMENT PLAN. STANCHART STEPS ON THE Y2K GAS
  • Abstracts: DANISH CO, IFU TO SET UP Rs25-M JV IN INDIA THAKRAL GROUP SETS UP RAFFLES IN INDIA ROOT CONSULTING SETS UP INDIAN ARM IN CHENNAI
  • Abstracts: NICHOLAS IN JV WITH BOOTS BAYER, ZYDUS GROUP IN PHARMA MARKETING JV ZYDUS IN JV WITH GERMAN MAJOR BYK GULDEN
  • Abstracts: PLOUGHING SUCCESS - PUNJAB TRACTORS PUNJAB TRACTORS NET JUMPS 36%. VST TILLERS TRACTORS ANNOUNCES BONUS
  • Abstracts: HALLMARK PLANNING 100% INDIAN OUTFIT TO COUNTER VINTAGE SNUB TISCO YET TO SOLVE HOLDINGS ISSUE WITH TIMKEN
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.